Searched for
UPENDRA KAUL
Made in India new generation heart stent receives major global recognitionAn Indian-made heart stent, Supraflex Cruz, has demonstrated a lower failure rate in high-risk patients compared to a US-made market leader...- Buy Havells India, target price Rs 1274: ICICI DirectHavells India, incorporated in the year 1983, is a Large Cap company (having a market cap of Rs 78971.55 Crore) operating in Consumer Durab...
- Buy Havells India, target price Rs 1225.5 : ICICI DirectPrice breakout above a falling supply line joining highs since December 2022 signalling resumption of the up move.
- Buy Havells India, target price Rs 1229: ICICI DirectPromoters held 59.45 per cent stake in the company as of 31-Dec-2022, while FIIs owned 22.6 per cent, DIIs 10.27 per cent.
- Buy Havells India, target price Rs 1550: ICICI SecuritiesHavells India, incorporated in the year 1983, is a Large Cap company (having a market cap of Rs 75140.45 Crore) operating in Consumer Durab...
- Buy Havells India, target price Rs 1236: ICICI DirectBuying demand emerging from the rising demand line joining last onemonths lows and 50 days EMA signalling strength.
- Buy Havells India, target price Rs 1550: ICICI SecuritiesNevertheless, it slashes earnings estimates to factor in muted consumer demand and subdued 9MFY23 performance.
- Buy Havells India, target price Rs 1170 : Axis SecuritiesHavells India, incorporated in the year 1983, is a Large Cap company (having a market cap of Rs 71970.11 Crore) operating in Consumer Durab...
- Buy Havells India, target price Rs 1550: ICICI SecuritiesHavells India, incorporated in the year 1983, is a Large Cap company (having a market cap of Rs 72524.57 Crore) operating in Consumer Durab...
- ‘Number’ refers to blood tests, says Yaseen Malik’s doctor to NIAMalik is in Tihar Jail in judicial custody in two cases, including one related to terror funding.
- It’s official, Indian-made stents as good as the bestA study presented two months back had also concluded that another Indian stent, Supra Flex was as good as Xience.
- Made in India coronary stents as good as foreign ones: StudyThe study dispels the perception among many doctors and patients that stents made in India may not be as safe and efficacious as those manu...
- 47.7 per cent people living in Delhi slum found to be overweightAlmost 64.9% of 314 individuals who were assessed during a camp were found either over-weight or obese, which are important risk factors fo...
- US stents dip in distribution in India after price capsAt the same time, Indian firms upped their share of the market to 61% in 2017 from 57% in 2016 after marginally increasing their distributi...
- SMT to conduct quality trials of its stents in EuropeThe company will test the quality, safety and efficacy of 86 variations of Supraflex stents against their Xience equivalents between now an...
- Capping stent prices will halt new launches, says industryThe process may require the drug pricing watchdog to look at a set of separate parameters for these devices as compared to that for drugs.
- Do's and Don'ts of fasting for heart patientsThere are several combination tablets which can be taken early morning before the start of fasting and after breaking the fast.
- Indian study on treating diabetics with heart ailments gets global recognitionAs per the findings, the use of Everolimus eluting stents may be equally or more useful in treating coronary blockages in diabetic patients...
- Ranbaxy sees churn at the top levelRanbaxy Laboratories is seeing some people movement with three senior executives leaving and its former HR head rejoining the company.
- New generation of drug-coated stents introducedAfter successful clinical studies in Europe, a new generation of drug-coated stents have been introduced for the first time in India at the...
Load More
